The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Healthcare CRO Market Research Report 2024
Synopsis
Contract research organizations (CROs) have transformed the way research are conducted by several pharmaceutical, biotechnology, and medical devices companies in ways more than one. These organizations offer a variety of services such as biopharmaceutical development, clinical trials conduct and other endeavors, drug discovery activities, product commercialization, assay development, and pharmacovigilance. The intensifying demand for new therapies and devices has mounted pressures on research and development (R&D) budgets of these organizations.
The global Healthcare CRO market was valued at US$ 88640 million in 2023 and is anticipated to reach US$ 155330 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
A significant driver in the Contract Research Organization (CRO) market is the increasing outsourcing trend in the pharmaceutical and biotechnology industries. CROs offer cost-efficiency, specialized expertise, and accelerated drug development processes, leading to their growing adoption. However, a notable challenge in this market is the need for quality control and data security. Ensuring data accuracy, confidentiality, and adherence to regulatory standards pose significant challenges for both CROs and their clients. Maintaining trust and transparency while mitigating potential risks is essential for sustaining the growth of the CRO market and fostering successful partnerships in the research and development sector.
This report aims to provide a comprehensive presentation of the global market for Healthcare CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare CRO.
Report Scope
The Healthcare CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Healthcare CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Healthcare CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Piramal
Strides Pharma
NextPharma
Famar
Jubilant
Alcami
Euroapi
Eurofins
Segment by Type
Early Phase Development
Clinical Research
Laboratory
Consulting Services
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contract research organizations (CROs) have transformed the way research are conducted by several pharmaceutical, biotechnology, and medical devices companies in ways more than one. These organizations offer a variety of services such as biopharmaceutical development, clinical trials conduct and other endeavors, drug discovery activities, product commercialization, assay development, and pharmacovigilance. The intensifying demand for new therapies and devices has mounted pressures on research and development (R&D) budgets of these organizations.
The global Healthcare CRO market was valued at US$ 88640 million in 2023 and is anticipated to reach US$ 155330 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
A significant driver in the Contract Research Organization (CRO) market is the increasing outsourcing trend in the pharmaceutical and biotechnology industries. CROs offer cost-efficiency, specialized expertise, and accelerated drug development processes, leading to their growing adoption. However, a notable challenge in this market is the need for quality control and data security. Ensuring data accuracy, confidentiality, and adherence to regulatory standards pose significant challenges for both CROs and their clients. Maintaining trust and transparency while mitigating potential risks is essential for sustaining the growth of the CRO market and fostering successful partnerships in the research and development sector.
This report aims to provide a comprehensive presentation of the global market for Healthcare CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare CRO.
Report Scope
The Healthcare CRO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Healthcare CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Healthcare CRO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Piramal
Strides Pharma
NextPharma
Famar
Jubilant
Alcami
Euroapi
Eurofins
Segment by Type
Early Phase Development
Clinical Research
Laboratory
Consulting Services
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Healthcare CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare CRO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Early Phase Development
1.2.3 Clinical Research
1.2.4 Laboratory
1.2.5 Consulting Services
1.3 Market by Application
1.3.1 Global Healthcare CRO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Healthcare CRO Market Perspective (2019-2030)
2.2 Healthcare CRO Growth Trends by Region
2.2.1 Global Healthcare CRO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Healthcare CRO Historic Market Size by Region (2019-2024)
2.2.3 Healthcare CRO Forecasted Market Size by Region (2025-2030)
2.3 Healthcare CRO Market Dynamics
2.3.1 Healthcare CRO Industry Trends
2.3.2 Healthcare CRO Market Drivers
2.3.3 Healthcare CRO Market Challenges
2.3.4 Healthcare CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare CRO Players by Revenue
3.1.1 Global Top Healthcare CRO Players by Revenue (2019-2024)
3.1.2 Global Healthcare CRO Revenue Market Share by Players (2019-2024)
3.2 Global Healthcare CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Healthcare CRO Revenue
3.4 Global Healthcare CRO Market Concentration Ratio
3.4.1 Global Healthcare CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare CRO Revenue in 2023
3.5 Healthcare CRO Key Players Head office and Area Served
3.6 Key Players Healthcare CRO Product Solution and Service
3.7 Date of Enter into Healthcare CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare CRO Breakdown Data by Type
4.1 Global Healthcare CRO Historic Market Size by Type (2019-2024)
4.2 Global Healthcare CRO Forecasted Market Size by Type (2025-2030)
5 Healthcare CRO Breakdown Data by Application
5.1 Global Healthcare CRO Historic Market Size by Application (2019-2024)
5.2 Global Healthcare CRO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Healthcare CRO Market Size (2019-2030)
6.2 North America Healthcare CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Healthcare CRO Market Size by Country (2019-2024)
6.4 North America Healthcare CRO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Healthcare CRO Market Size (2019-2030)
7.2 Europe Healthcare CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Healthcare CRO Market Size by Country (2019-2024)
7.4 Europe Healthcare CRO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Healthcare CRO Market Size (2019-2030)
8.2 Asia-Pacific Healthcare CRO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Healthcare CRO Market Size by Region (2019-2024)
8.4 Asia-Pacific Healthcare CRO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Healthcare CRO Market Size (2019-2030)
9.2 Latin America Healthcare CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Healthcare CRO Market Size by Country (2019-2024)
9.4 Latin America Healthcare CRO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare CRO Market Size (2019-2030)
10.2 Middle East & Africa Healthcare CRO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Healthcare CRO Market Size by Country (2019-2024)
10.4 Middle East & Africa Healthcare CRO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Healthcare CRO Introduction
11.1.4 Lonza Revenue in Healthcare CRO Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Healthcare CRO Introduction
11.2.4 Catalent Revenue in Healthcare CRO Business (2019-2024)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Healthcare CRO Introduction
11.3.4 Thermo Fisher Scientific Revenue in Healthcare CRO Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Detail
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Healthcare CRO Introduction
11.4.4 Samsung Biologics Revenue in Healthcare CRO Business (2019-2024)
11.4.5 Samsung Biologics Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Healthcare CRO Introduction
11.5.4 Fareva Revenue in Healthcare CRO Business (2019-2024)
11.5.5 Fareva Recent Development
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Detail
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Healthcare CRO Introduction
11.6.4 WuXi AppTech Revenue in Healthcare CRO Business (2019-2024)
11.6.5 WuXi AppTech Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Healthcare CRO Introduction
11.7.4 WuXi Biologics Revenue in Healthcare CRO Business (2019-2024)
11.7.5 WuXi Biologics Recent Development
11.8 Siegfried
11.8.1 Siegfried Company Detail
11.8.2 Siegfried Business Overview
11.8.3 Siegfried Healthcare CRO Introduction
11.8.4 Siegfried Revenue in Healthcare CRO Business (2019-2024)
11.8.5 Siegfried Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Healthcare CRO Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Healthcare CRO Business (2019-2024)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Detail
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Healthcare CRO Introduction
11.10.4 Asymchem Revenue in Healthcare CRO Business (2019-2024)
11.10.5 Asymchem Recent Development
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Detail
11.11.2 Pfizer CentreOne Business Overview
11.11.3 Pfizer CentreOne Healthcare CRO Introduction
11.11.4 Pfizer CentreOne Revenue in Healthcare CRO Business (2019-2024)
11.11.5 Pfizer CentreOne Recent Development
11.12 Delpharm
11.12.1 Delpharm Company Detail
11.12.2 Delpharm Business Overview
11.12.3 Delpharm Healthcare CRO Introduction
11.12.4 Delpharm Revenue in Healthcare CRO Business (2019-2024)
11.12.5 Delpharm Recent Development
11.13 Recipharm
11.13.1 Recipharm Company Detail
11.13.2 Recipharm Business Overview
11.13.3 Recipharm Healthcare CRO Introduction
11.13.4 Recipharm Revenue in Healthcare CRO Business (2019-2024)
11.13.5 Recipharm Recent Development
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Detail
11.14.2 AGC Pharma Chemicals Business Overview
11.14.3 AGC Pharma Chemicals Healthcare CRO Introduction
11.14.4 AGC Pharma Chemicals Revenue in Healthcare CRO Business (2019-2024)
11.14.5 AGC Pharma Chemicals Recent Development
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Detail
11.15.2 Boehringer Ingelheim Business Overview
11.15.3 Boehringer Ingelheim Healthcare CRO Introduction
11.15.4 Boehringer Ingelheim Revenue in Healthcare CRO Business (2019-2024)
11.15.5 Boehringer Ingelheim Recent Development
11.16 Vetter
11.16.1 Vetter Company Detail
11.16.2 Vetter Business Overview
11.16.3 Vetter Healthcare CRO Introduction
11.16.4 Vetter Revenue in Healthcare CRO Business (2019-2024)
11.16.5 Vetter Recent Development
11.17 Curia
11.17.1 Curia Company Detail
11.17.2 Curia Business Overview
11.17.3 Curia Healthcare CRO Introduction
11.17.4 Curia Revenue in Healthcare CRO Business (2019-2024)
11.17.5 Curia Recent Development
11.18 Aenova
11.18.1 Aenova Company Detail
11.18.2 Aenova Business Overview
11.18.3 Aenova Healthcare CRO Introduction
11.18.4 Aenova Revenue in Healthcare CRO Business (2019-2024)
11.18.5 Aenova Recent Development
11.19 Porton
11.19.1 Porton Company Detail
11.19.2 Porton Business Overview
11.19.3 Porton Healthcare CRO Introduction
11.19.4 Porton Revenue in Healthcare CRO Business (2019-2024)
11.19.5 Porton Recent Development
11.20 Piramal
11.20.1 Piramal Company Detail
11.20.2 Piramal Business Overview
11.20.3 Piramal Healthcare CRO Introduction
11.20.4 Piramal Revenue in Healthcare CRO Business (2019-2024)
11.20.5 Piramal Recent Development
11.21 Strides Pharma
11.21.1 Strides Pharma Company Detail
11.21.2 Strides Pharma Business Overview
11.21.3 Strides Pharma Healthcare CRO Introduction
11.21.4 Strides Pharma Revenue in Healthcare CRO Business (2019-2024)
11.21.5 Strides Pharma Recent Development
11.22 NextPharma
11.22.1 NextPharma Company Detail
11.22.2 NextPharma Business Overview
11.22.3 NextPharma Healthcare CRO Introduction
11.22.4 NextPharma Revenue in Healthcare CRO Business (2019-2024)
11.22.5 NextPharma Recent Development
11.23 Famar
11.23.1 Famar Company Detail
11.23.2 Famar Business Overview
11.23.3 Famar Healthcare CRO Introduction
11.23.4 Famar Revenue in Healthcare CRO Business (2019-2024)
11.23.5 Famar Recent Development
11.24 Jubilant
11.24.1 Jubilant Company Detail
11.24.2 Jubilant Business Overview
11.24.3 Jubilant Healthcare CRO Introduction
11.24.4 Jubilant Revenue in Healthcare CRO Business (2019-2024)
11.24.5 Jubilant Recent Development
11.25 Alcami
11.25.1 Alcami Company Detail
11.25.2 Alcami Business Overview
11.25.3 Alcami Healthcare CRO Introduction
11.25.4 Alcami Revenue in Healthcare CRO Business (2019-2024)
11.25.5 Alcami Recent Development
11.26 Euroapi
11.26.1 Euroapi Company Detail
11.26.2 Euroapi Business Overview
11.26.3 Euroapi Healthcare CRO Introduction
11.26.4 Euroapi Revenue in Healthcare CRO Business (2019-2024)
11.26.5 Euroapi Recent Development
11.27 Eurofins
11.27.1 Eurofins Company Detail
11.27.2 Eurofins Business Overview
11.27.3 Eurofins Healthcare CRO Introduction
11.27.4 Eurofins Revenue in Healthcare CRO Business (2019-2024)
11.27.5 Eurofins Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
